Medication info
Albozen Carvedilol Tablet 12.5 mg (Carvedilol)

Albozen Carvedilol Tablet 12.5 mg (Carvedilol)

Prescription medicationTabletOral
Ingredient · strength
Carvedilol›12.5mg / 1 tablet
Manufacturer / importer
Albozen Korea Co., Ltd.
Appearance
Reddish-brown round tablets
Packaging
100 tablets (10 tablets/PTP X 10)
Approval status
Active

MFDS item code 200702200 · Notified 2007.02.20 · Insurance code 652603000

Summary

Main use
Treatment of essential hypertension and chronic stable angina; adjunctive treatment of congestive heart failure
Who takes it
Adults
Adult dose
Do not increase the dose or stop taking this medicine without your doctor's instructions. 1. Essential hypertension 1) Adults (1) For the first 2 days, administer 12.5 mg of carvedilol orally once daily, then administer 25 mg orally once daily. (2) The usual dosage is 25 mg orally once daily for 2 weeks. If an increase is needed, increase to 25 mg per dose twice daily. The maximum dose per administration is 25 mg, and the maximum daily dose is 50 mg. 2) Older adults In some older adults, 12.5 mg once daily may be sufficient to produce an adequate effect. However, the dose may be increased if the effect is insufficient after 2 weeks of administration. 2. Chronic stable angina 1) For the first 2 days, administer 12.5 mg of this medicine per dose twice daily orally, then administer 25 mg per dose twice daily orally. 2) The usual dosage is 25 mg per dose twice daily for 2 weeks. If an increase is needed (excluding older adults), the dose may be increased to 50 mg per dose twice daily. 3. Congestive heart failure Before starting treatment with this medicine, the patient's existing standard treatment regimen (conventional treatment for chronic heart failure with an ACE inhibitor, a diuretic, and usually a digitalis preparation) must be stable. Fluid retention should also be minimized before starting treatment with this medicine. 1) The usual initial dosage is 3.125 mg of this medicine per dose twice daily orally for 2 weeks. If the patient tolerates this treatment well, increase the dose to 6.25 mg per dose twice daily for 2 weeks, then to 12.5 mg per dose twice daily for 2 weeks, and then to 25 mg per dose twice daily. 2) After taking each dose for at least 2 weeks, gradually increase the dose to the highest dose the patient can tolerate. 3) The minimum effective dose is 6.25 mg per dose twice daily. The maximum dose is 25 mg per dose twice daily for patients weighing 85 kg or less, and 50 mg per dose twice daily for patients weighing more than 85 kg. 4) To control the rate of absorption, it is recommended that the medicine be taken with meals in the morning and evening. Taking it with meals slows the rate of absorption and may reduce the incidence of orthostatic hypotension.

Ingredients

Manufacturer
Albozen Korea Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and chronic stable angina; adjunctive treatment of congestive heart failure

  • Essential hypertension
  • chronic stable angina
  • congestive heart failure
View approved original text

This medication is used for cardiovascular diseases such as essential hypertension, chronic stable angina, and congestive heart failure. It is particularly utilized as an adjunct therapy along with diuretics, digitalis preparations, ACE inhibitors, and other vasodilators to help improve patient symptoms and treatment efficacy. This treatment contributes to blood pressure control and cardiac function improvement.

How to take

Adult dose

Do not increase the dose or stop taking this medicine without your doctor's instructions. 1. Essential hypertension 1) Adults (1) For the first 2 days, administer 12.5 mg of carvedilol orally once daily, then administer 25 mg orally once daily. (2) The usual dosage is 25 mg orally once daily for 2 weeks. If an increase is needed, increase to 25 mg per dose twice daily. The maximum dose per administration is 25 mg, and the maximum daily dose is 50 mg. 2) Older adults In some older adults, 12.5 mg once daily may be sufficient to produce an adequate effect. However, the dose may be increased if the effect is insufficient after 2 weeks of administration. 2. Chronic stable angina 1) For the first 2 days, administer 12.5 mg of this medicine per dose twice daily orally, then administer 25 mg per dose twice daily orally. 2) The usual dosage is 25 mg per dose twice daily for 2 weeks. If an increase is needed (excluding older adults), the dose may be increased to 50 mg per dose twice daily. 3. Congestive heart failure Before starting treatment with this medicine, the patient's existing standard treatment regimen (conventional treatment for chronic heart failure with an ACE inhibitor, a diuretic, and usually a digitalis preparation) must be stable. Fluid retention should also be minimized before starting treatment with this medicine. 1) The usual initial dosage is 3.125 mg of this medicine per dose twice daily orally for 2 weeks. If the patient tolerates this treatment well, increase the dose to 6.25 mg per dose twice daily for 2 weeks, then to 12.5 mg per dose twice daily for 2 weeks, and then to 25 mg per dose twice daily. 2) After taking each dose for at least 2 weeks, gradually increase the dose to the highest dose the patient can tolerate. 3) The minimum effective dose is 6.25 mg per dose twice daily. The maximum dose is 25 mg per dose twice daily for patients weighing 85 kg or less, and 50 mg per dose twice daily for patients weighing more than 85 kg. 4) To control the rate of absorption, it is recommended that the medicine be taken with meals in the morning and evening. Taking it with meals slows the rate of absorption and may reduce the incidence of orthostatic hypotension.

Precautions

This drug should not be used in patients with certain diseases or conditions. For example, it may worsen cardiac function in patients with cardiogenic shock, severe bradycardia, or cardiac conduction abnormalities. Additionally, it should be avoided in patients with respiratory diseases like asthma or chronic obstructive pulmonary disease, as it may induce bronchospasm. In diabetic patients with ketoacidosis or metabolic acidosis, it can suppress myocardial contractility and worsen the condition. Women who are pregnant or breastfeeding should avoid taking this medication as it may pose risks to the fetus or newborn. This drug can lower blood pressure and heart rate, therefore, patients with hypotension or severely weak cardiac function should use it with caution. Symptoms such as dizziness, fatigue, and headache may occur during treatment, and in severe cases, serious side effects like heart failure or cardiac arrest may occur, requiring regular cardiac function monitoring. Dosage adjustments may be necessary for patients with impaired kidney or liver function due to slower drug metabolism. This drug can interact with various medications, so patients taking other blood pressure medications, diabetes medications, antidepressants, or sedatives should consult their physician or pharmacist. Sudden discontinuation of this medication may worsen symptoms; thus, it should be tapered under medical supervision. Caution is advised when performing risky tasks such as driving or operating machinery as drowsiness or dizziness may occur. This drug is sensitive to light, so it should be stored in a light-protected, tightly closed container away from children.

Side effects

  • Dizziness
  • headache
  • fatigue
  • weakness
  • hallucinations
  • confusion
  • depression
  • sleep disorders
  • nightmares
  • psychosis
Show 53 more
  • severe bradycardia
  • shock
  • complete atrioventricular block
  • heart failure
  • cardiac arrest
  • hypotension
  • loss of consciousness
  • decreased pulse rate
  • cold extremities
  • edema
  • cardiac arrest
  • worsening renal function
  • renal failure
  • increased airway resistance
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • constipation
  • urticaria
  • itching
  • lichen planus-like reaction
  • sweating
  • allergic rash
  • thrombocytopenia
  • leukopenia
  • hypoglycemia
  • concealed hyperfunction of the thyroid
  • bradycardia
  • hypotension
  • shortness of breath
  • angina
  • liver dysfunction
  • jaundice
  • limb pain
  • decreased tear production
  • sensory disturbances
  • visual disturbances
  • eye irritation
  • dry mouth
  • urinary disorders
  • sexual dysfunction
  • allergic reaction
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • blood pressure reduction
  • myocardial depression
  • cardiac arrest
  • dyspnea
  • bronchospasm
  • vomiting
  • consciousness disorder
  • generalized seizure

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to light and should be stored in a container that blocks light. Furthermore, it is important to store it at room temperature between 1°C and 30°C to maintain its effectiveness.

Appearance and packaging

Appearance

Reddish-brown round tablets

Package unit

100 tablets (10 tablets/PTP X 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.